Clinical Trial Update: Post C-Section Pain Control Using EXPAREL [Phase 4]

View source ↗

Summary

Phase 4 post-approval trial for EXPAREL in post-cesarean section pain control was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: University of Minnesota | Conditions: Pain, Postoperative | Phase 4 | Status: WITHDRAWN